All posts tagged
Meet the Founder & CEO of Galapagos, Europe’s Biotech Role Model
The 7 Best Biotech Companies in Europe’s History
Belgian Biotech Takes Down Untreatable Lung Disease in Phase II, Eyes the Market
Belgian Biotech Passes Go and May Collect €290M for Arthritis Drug’s Progress
Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year
With Actelion’s Acquisition Done, What are the Largest European Biotechs?
BRIEF: Galapagos and Gilead add Lupus to their Growing List of Indications
Galapagos Shoots Past its IPO in a New Public Round of €315M
Galapagos Launches 3 New Trials to Expand into Profitable Indications
Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug
What are the Best Countries to Recruit Biotech Talents in 2017?
Galapagos finds a Partner to Boost its Pipeline with Drug Combinations
Labiotech UG, All Rights Reserved -
Send this to a friend